|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/198 | |
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/14 | |||
| A61P 25/04 |
| (11) | Patento numeris | 3228313 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17170079.2 |
| Europos patento paraiškos padavimo data | 2014-01-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361849191 P | 2013-01-22 | US |
| (72) |
Snodgrass, Ralph H., US
Cato, Allen E., US
Hicklin, Jack S., US
|
| (73) |
Vistagen Therapeutics, Inc.,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |